Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$4.76
-2.9%
$5.70
$2.90
$11.16
$386.07M0.473.34 million shs6.33 million shs
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$6.01
+2.8%
$4.78
$1.18
$7.77
$645.10M2.575.11 million shs3.75 million shs
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
$164.22
+0.3%
$161.04
$141.38
$183.60
$1.02B0.7924,067 shs5,323 shs
ILA
iLOOKABOUT Corp. (ILA.V)
C$0.59
+15.7%
C$0.59
C$0.11
C$0.75
C$96.75MN/A2.09 million shs1.75 million shs
Penumbra, Inc. stock logo
PEN
Penumbra
$250.54
+0.3%
$269.14
$148.00
$310.00
$9.72B0.47454,147 shs233,847 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
0.00%+36.00%-12.82%+12.26%-27.88%
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
0.00%+4.96%+20.04%+155.91%+260.12%
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
0.00%+1.81%+1.37%+7.51%+7.76%
ILA
iLOOKABOUT Corp. (ILA.V)
0.00%0.00%0.00%0.00%0.00%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%-2.18%-3.04%-4.51%+41.20%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
2.2387 of 5 stars
3.51.00.00.02.51.70.6
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
1.8171 of 5 stars
1.02.00.01.72.41.70.6
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/AN/AN/AN/A
ILA
iLOOKABOUT Corp. (ILA.V)
N/AN/AN/AN/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
4.7299 of 5 stars
3.43.00.03.73.42.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
3.00
Buy$19.00299.16% Upside
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
2.00
Hold$3.33-44.57% Downside
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
2.66
Moderate Buy$164.22N/A
ILA
iLOOKABOUT Corp. (ILA.V)
0.00
N/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
2.88
Moderate Buy$302.4020.70% Upside

Current Analyst Ratings Breakdown

Latest ILA, FBT, ALT, PEN, and APPS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
Altimmune, Inc. stock logo
ALT
Altimmune
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
6/27/2025
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
6/17/2025
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$4.00 ➝ $7.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00 ➝ $330.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$301.00 ➝ $318.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$315.00 ➝ $330.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$315.00 ➝ $330.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$305.00 ➝ $315.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$316.00 ➝ $325.00
4/15/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$315.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$20K19,304.18N/AN/A$1.74 per share2.74
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$490.51M1.31$0.82 per share7.35$1.47 per share4.09
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/AN/A
ILA
iLOOKABOUT Corp. (ILA.V)
C$19.51M4.96C$0.07 per share8.48C$0.11 per share5.41
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B8.12$2.88 per share86.97$29.99 per share8.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$95.06M-$1.26N/AN/AN/A-451,200.00%-65.44%-58.43%8/6/2025 (Estimated)
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
-$92.10M-$0.89N/A120.28N/A-18.61%1.89%0.39%8/6/2025 (Estimated)
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/A21.72N/AN/AN/AN/AN/A
ILA
iLOOKABOUT Corp. (ILA.V)
N/A-C$0.04N/AN/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$1.06236.3650.012.243.41%11.14%8.40%7/29/2025 (Estimated)

Latest ILA, FBT, ALT, PEN, and APPS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81N/AN/AN/A$327.37 millionN/A
6/16/2025Q4 2025
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
$0.05$0.10+$0.05-$0.18$116.64 million$119.15 million
5/13/2025Q1 2025
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.26+$0.09-$0.26$0.00 million$0.01 million
4/23/2025Q1 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.66$0.83+$0.17$1.00$315.72 million$324.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
N/AN/AN/AN/AN/A
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
$1.170.71%N/AN/AN/A
ILA
iLOOKABOUT Corp. (ILA.V)
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
15.85
15.85
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
2.66
1.09
1.09
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/A
ILA
iLOOKABOUT Corp. (ILA.V)
64.23
1.87
1.76
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.30
3.68
CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5081.11 million77.78 millionOptionable
Digital Turbine, Inc. stock logo
APPS
Digital Turbine
840106.98 million100.78 millionOptionable
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/A6.20 millionN/ANot Optionable
ILA
iLOOKABOUT Corp. (ILA.V)
28163.99 millionN/ANot Optionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50038.73 million37.10 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Altimmune stock logo

Altimmune NASDAQ:ALT

$4.76 -0.14 (-2.86%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$4.76 +0.00 (+0.08%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Digital Turbine stock logo

Digital Turbine NASDAQ:APPS

$6.01 +0.16 (+2.80%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$5.98 -0.04 (-0.65%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Digital Turbine, Inc., through its subsidiaries, operates a mobile growth platform for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The company operates through two segments, On Device Solutions and App Growth Platform. Its application media platform delivers mobile applications to various publishers, carriers, OEMs, and devices; and content media platform offers news, weather, sports, and other content, as well as programmatic advertising and media content delivery services, and sponsored and editorial content media. The company also provides direct campaign management products, such as the DT DSP and DT Offer Wall; ad monetization solutions allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising; brands and agencies runs mobile brand-awareness campaigns on the direct mobile app inventory; and app developers and other performance-focused advertisers execute mobile user acquisition campaigns for their apps and products. It operates in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, China, Mexico, Central America, and South America. The company is headquartered in Austin, Texas.

First Trust NYSE Arca Biotechnology Index Fund stock logo

First Trust NYSE Arca Biotechnology Index Fund NYSEARCA:FBT

$164.22 +0.46 (+0.28%)
As of 07/3/2025 05:00 PM Eastern

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

iLOOKABOUT Corp. (ILA.V) CVE:ILA

C$0.59 +0.08 (+15.69%)
As of 02/4/2021

iLOOKABOUT Corp., together with its subsidiaries, provides software and data licenses and technology managed services to the real estate industry in Canada and the United States. The company offers GeoViewPort, a web-based platform that enables assessment professionals to simultaneously generate customized portals to view multiple elements related to a property, including street level imagery, aerial imagery, advanced mapping tools, property valuation details, comparable property analysis, and structural characteristics. It also provides FusionOMSm, a web-based platform that enables real property valuation solutions to enterprises through US nationwide repository of public record and multiple listing service data; and Real Property Tax Analytics, a web-based platform that analyzes property assessments. In addition, the company offers data commercialization products and services through the delivery of reports and individual data requests to users through e-commerce transactions or by account, as well as customized reports through an assisted fulfillment process. Further, it provides valuation management and property tax solutions, which include assessment base management, analytics reports, tax policy planning and support, and appeals management. It primarily serves property lending and property tax sectors. iLOOKABOUT Corp. was founded in 2000 and is based in London, Canada.

Penumbra stock logo

Penumbra NYSE:PEN

$250.54 +0.80 (+0.32%)
Closing price 07/3/2025 03:53 PM Eastern
Extended Trading
$250.54 0.00 (0.00%)
As of 07/3/2025 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.